Blocklisting Interim Review
January 07 2008 - 11:17AM
UK Regulatory
RNS Number:2484L
Sagentia Group AG
07 January 2008
BLOCK LISTING RETURN
To:
Listing Applications
UK Listing Authority
Financial Services Authority
25 The North Colonade
Canary Wharf
London E14 5HS
Subject Information
Name of Company Sagentia Group AG
Name of Schemes 2000 Unapproved
2005 Unapproved (EMI)
2001 Approved
2005 EIS Unapproved
Period of return 05/01/2007 - 03/01/2008
Balance under schemes not yet issued/allotted from 12,130,683 (2000
previous return Unapproved)
3,814,343 (2001 Approved)
171,829 (2005 Unapproved
(EMI))
Total 16,116,855
The amount by which the schemes have been increased 1,350,967 (2000 Unapproved)
since the date of the last return
Number of shares issued/allotted under schemes 11,193,834 (2000
during period Unapproved)
Balance under schemes not yet issued/allotted at the 2,287,816 (2000 Unapproved)
end of the period
3,814, 343 (2001 Approved )
171,829 (2005 Unapproved
(EMI))
Total 6,273,988
Number and class of share(s) 11,916,000 (September 2000
Unapproved)
(amount of stock/debt securities) 4,300,000 (April 2003
Approved)
originally listed and the date of admission 11,755,946 (June 2005
Unapproved (EMI))
Total number of securities in issue at the end of 25,809,235 Ordinary Shares
the period of 0.10 CHF each.
Please confirm the total number of shares in issue at the end of the period in
order for us to up date our records:
215,965,577 shares
Name of Contact for Queries: Helen Barrett-Hague
Address: Sagentia Group Limited
Harston Mill
Harston
Cambridge
CB22 7GG
Telephone number: 01223 875467
Notes to editors:
Sagentia Group AG
Sagentia Group is a leading international technology consulting and venturing
organisation, with a reputation for successfully commercialising emerging
science and technology. The Group comprises two principal operating companies,
Sagentia and Chord Capital.
Sagentia is one of the world's pre-eminent technology management and product
development companies. For 20 years the business has shown an unwavering
commitment to innovation that has led to the launch of breakthrough products and
services.
Sagentia's facilities include state-of-the-art laboratories and are located in
Europe the USA and Hong Kong.
The Group's venture management activities are managed through its FSA-regulated
fund manager Chord Capital Limited. Through Chord Capital, venture and investee
companies gain access to business building and corporate finance skills. Recent
ventures and investments include CMR Fuel Cells plc and Nanoscience plc, listed
on AIM, Sphere Medical Ltd and Atraverda Ltd.
Sagentia Group is quoted on the LSE (SGA.L)
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRILFLRLSIDIIT
Sagentia Grp (LSE:SGA)
Historical Stock Chart
From Dec 2024 to Jan 2025
Sagentia Grp (LSE:SGA)
Historical Stock Chart
From Jan 2024 to Jan 2025